APOBEC3B and breast carcinoma: Expression of APOBEC3B is upregulated in breast cancer and it was associated with kataegis, aggressive clinical and pathological features of breast tumors, and poor prognosis among patients with estrogen receptor-positive (ER+) breast cancer [34].